- adult prevalence rate people: hiv/aids - people living with hiv/aids people: hiv/aids - deaths people: literacy economy: gdp economy: gdp - real growth rate economy: gdp - per capita economy: population below poverty line economy: inflation rate (consumer prices) economy: labor force economy: unemployment...
- adult prevalence rate people: hiv/aids - people living with hiv/aids people: hiv/aids - deaths people: literacy economy: gdp economy: gdp - real growth rate economy: gdp - per capita economy: population below poverty line economy: inflation rate (consumer prices) economy: labor force economy: unemployment...
- adult prevalence rate people: hiv/aids - people living with hiv/aids people: hiv/aids - deaths people: literacy economy: gdp economy: gdp - real growth rate economy: gdp - per capita economy: population below poverty line economy: inflation rate (consumer prices) economy: labor force economy: unemployment...
use of dolutegravir-based or low-dose efavirenz for first-line therapy, and raltegravir and darunavir/ritonavir for second line as recommended by who. making the access to the treatment and prevention is the core goal for the upcoming year. and this aims to bring the world back on track to end the aids...